1. Home
  2. Buyout

Category: Insight

LPs planning big renewable energy infrastructure investment push as climate change response grows

Global institutional investors plan to almost double their allocations to renewable energy infrastructure in the near-term as the global response to climate change continues to gain momentum.

BGF backs human cell disease model startup DefiniGEN

UK investment house BGF has backed a £3.25m funding round for DefiniGEN, a provider of human cell products and services.

Vista Equity Partners helps Pipedrive hit unicorn status through majority investment

Software-focused private equity major Vista Equity Partners has helped CRM platform Pipedrive reach unicorn status through a majority investment.

German resilience helps DACH region towards record PE deal value total despite Covid-19 volatility

German resilience is helping the DACH region power towards its highest annual private equity deal value total for a decade despite the bruising impact of the coronavirus pandemic on firms across the globe.

GPs must embrace proactive portfolio management tools now, or be left behind

As the coronavirus crisis continues to rage across the glove, private equity investors are being forced to think more carefully about managing their existing portfolios amid a volatile dealmaking market. AltAssets spoke to Eaton Partners'…

Discover the sectors surviving Covid-19’s private equity buy-and-build slump

Private equity buy-and-build activity has suffered a heavy blow through the coronavirus pandemic, with activity dropping to a five-year low according to new data from Silverfleet Capital.

Venture capital investment stays strong through Covid chaos despite ongoing deal numbers slump

Global venture capital investment remains strong despite dealmaking numbers dropping for the sixth consecutive quarter, new research shows, with a trio of $1bn-plus deals from across the globe helping buoy the industry's figures.

Biotech sector sees huge year-on-year private equity, venture capital investment activity jump as Covid recovery continues

Private equity and venture capital investment in the biotech sector has scored its busiest month of the past 12 as markets continue their recovery from March's coronavirus shock.

Covid forcing newer private equity firms out of fundraising while veteran operators raise huge amounts

European private equity fundraising activity has come roaring back in the third quarter thanks to a slew of big fund closes - but the coronavirus pandemic is forcing many less-established GPs out of the capital…

Second wave of Covid-19 biggest threat to fund managers eyeing LP capital – survey

LPs fears over a second wave of the Covid-19 pandemic is the biggest threat to alternative asset fund managers looking to raise new capital, new research shows.

Summa Equity picks up majority stake in protein production, research specialist Sengenics

Stockholm's Summa Equity has bought a majority stake in protein production and research specialist Sengenics through its €610m second fund.

US VC exits surge to huge quarterly total despite Covid uncertainty, fundraising on track for record year, new research shows

US venture capital exit activity has hit its second-highest value ever recorded despite global volatility in recent months due to the coronavirus crisis, new research shows.

PE, VC fundraising remains at ‘full throttle’ despite LP pullback amid Covid-19

Private equity and venture capital fundraising efforts remain at full throttle despite a tightening up of LP commitments to alternatives in the face of the Covid-19 pandemic, new research shows.

Private equity returns fall to six-year low as buyout firms fail to escape coronavirus chaos

Private equity returns suffered a severe drop in the first half of the year as the long-time booming asset class failed to escape the chaos of the coronavirus crisis, new research shows.

Global LBO returns see sharp decline in H1 2020 – research

The coronavirus pandemic hit returns for leveraged buyouts sharply in the first half of 2020, according to a private equity performance report by eFront.

PE firms increasingly paying themselves dividends through new portfolio company debt – report

Private equity firms are using portfolio company loans to pay themselves dividends at the highest ratio in five years as demand for corporate debt soars amid the coronavirus crisis.

Private equity dealmaking continues recovery with one of best results of last 12 months

Private equity dealmaking is continuing its steady recovery from April's nadir, reaching one of its highest monthly results of the last 12 months despite ongoing uncertainty amid the coronavirus crisis.

Credit Suisse adds 11 to China JV research team

Credit Suisse has hired 11 researchers for Credit Suisse Founder Securities (CSFS), its Chinese joint venture securities house. The new employees are part of the bank’s bigger plan to expand its onshore presence.

Pandemic fails to shackle European alternatives as AUM reaches €2tn for first time

European alternatives funds have reached €2tn of assets under management for the first time despite a dampening of activity amid the coronavirus pandemic.

VC performance ‘unscathed’ by Covid-19 in Q1 as industry consolidates exceptional 2019 – eFront

Venture capital performance remained 'unscathed' in the first quarter of 2020 despite the onset of the coronavirus pandemic, as the industry consolidated what had been an exceptional 2019, new research shows.